Literature DB >> 6184423

Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid.

H Kobayashi, K Hashimoto.   

Abstract

Epidermal keratin was extracted and antibody against this protein was produced in rabbits. Various forms of organ-limited cutaneous amyloidosis (lichenoid, macular, and nodular amyloidosis, and basal cell epithelioma) and primary systemic amyloidosis were immunohistochemically examined to test the identity between epidermal keratin and skin amyloid. Amyloids in lichenoid and macular amyloidoses, and in basal cell epithelioma had an identical antigenicity with epidermal keratin, whereas amyloids in nodular amyloidosis and systemic amyloidosis did not have this identity. In addition, amyloid in lichen amyloidosis contained disulfide bonds as in keratin. Connective tissue components including filaments of fibroblasts and vascular endothelial cells did not react with this antikeratin antibody. It was concluded that at least some of the amyloid substance in organ-limited cutaneous amyloidosis is derived from degenerated epidermal keratinocytes through filamentous degeneration or apoptosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6184423     DOI: 10.1111/1523-1747.ep12531130

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Two different pathogenetic pathways in lichen amyloidosus and macular amyloidosis.

Authors:  P Westermark; P Norén
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 2.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

3.  Differential staining of cytoid bodies and skin-limited amyloids with monoclonal anti-keratin antibodies.

Authors:  H Eto; K Hashimoto; H Kobayashi; T Fukaya; M Matsumoto; T T Sun
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

4.  Localized amyloidosis in squamous cell carcinoma of uterine cervix: electron microscopic features of nodular and star-like amyloid deposits.

Authors:  T Gondo; T Ishihara; H Kawano; F Uchino; M Takahashi; T Iwata; N Matsumoto; T Yokota
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  In vitro amyloidogenic peptides of galectin-7: possible mechanism of amyloidogenesis of primary localized cutaneous amyloidosis.

Authors:  Koji Ono; Eita Fujimoto; Norihiro Fujimoto; Minoru Akiyama; Takahiro Satoh; Hiroki Maeda; Noriko Fujii; Shingo Tajima
Journal:  J Biol Chem       Date:  2014-08-29       Impact factor: 5.157

6.  Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis.

Authors:  Ken Arita; Andrew P South; Günter Hans-Filho; Thais Harumi Sakuma; Joey Lai-Cheong; Suzanne Clements; Maçanori Odashiro; Danilo Nakao Odashiro; Günter Hans-Neto; Nelise Ritter Hans; Maxine V Holder; Balbir S Bhogal; Sian T Hartshorne; Masashi Akiyama; Hiroshi Shimizu; John A McGrath
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

7.  Antikeratin autoantibodies in the amyloid deposits of lichen amyloidosus and macular amyloidosis.

Authors:  K Ito; K Hashimoto
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

8.  Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis.

Authors:  Audra L Clos; Rakez Kayed; Cristian A Lasagna-Reeves
Journal:  Front Neurol       Date:  2012-01-20       Impact factor: 4.003

9.  Fibulin-4 Accelerates Amyloid Formation by Binding with a Keratin 5 Peptide Fragment.

Authors:  Fumihiko Katagiri; Daisuke Ueo; Yumi Okubo-Gunge; Aya Usui; Sayaka Kuwatsuka; Yoshiko Mine; Keisuke Hamada; Sakuhei Fujiwara; Takako Sasaki; Motoyoshi Nomizu; Atsushi Utani
Journal:  JID Innov       Date:  2022-03-09

10.  A clinico-epidemiological study of macular amyloidosis from north India.

Authors:  Anshu Bandhlish; Asok Aggarwal; Ravinder V Koranne
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.